# EDGAR Filing Document

**Accession Number:** 0001553846
**File Stem:** 0001178913-25-002258
**Filing Date:** 2025-6
**Character Count:** 2280
**Document Hash:** 3798a5d33350cdbaf71ea354ed64e3c9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-25-002258.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0001178913-25-002258

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RedHill Biopharma Ltd.
- **CENTRAL INDEX KEY:** 0001553846
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 21 HA'ARBA'A STREET
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 64739
- **BUSINESS PHONE:** 972-3-541-3131

**MAIL ADDRESS:**
- **STREET 1:** 21 HA'ARBA'A STREET
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 64739

------

#### RedHill Biopharma Ltd.
21 Ha'arba'a Street

Tel Aviv, 6473921, Israel

June 30, 2025

#### VIA EDGAR
United States Securities and Exchange Commission<br> Division of Corporation Finance

Office of Life Sciences

100 F Street N.E.<br> Washington, D.C. 20549

Attention: Lauren Hamill

Re: RedHill Biopharma Ltd.<br> Registration Statement on Form F-1

Filed June 25, 2025

File No. 333-288324 (the "***Registration Statement***")

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, RedHill Biopharma Ltd. (the "***Company***") hereby respectfully requests that the effective date of the Company's Registration Statement be accelerated by the Securities and Exchange Commission to 4:00 p.m., Eastern Time on July 2, 2025, or as soon thereafter as practicable.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to the Company's counsel, Haynes and Boone, LLP, by calling Jayun Koo at (212) 835-4823, and that such effectiveness also be confirmed in writing.

---

| | |
|:---|:---|
| Very truly yours,<br>REDHILL BIOPHARMA LTD. | Very truly yours,<br>REDHILL BIOPHARMA LTD. |
| By:  | */s/ Dror Ben-Asher* |
|  | Dror Ben-Asher<br> Chief Executive Officer and Chairman of the Board of Directors |

---

cc: Rick A. Werner, Esq., Haynes and Boone, LLP <br> Jayun Koo, Esq., Haynes and Boone, LLP

------